New study sheds light on how disease progression and biomolecular corona affect nanoparticle-mediated immune activation.

Research from the lab of Jana Shen looks at a mutation causing diminished effectiveness of Paxlovid.

Regulatory science center will receive up to $50 million over five years.

Aziza Frank is a PhD candidate in the Department of Pharmaceutical Sciences.

School received more than $25 million for research in the fiscal year 2022.

Event enhances collaboration between two Baltimore institutions.

PSC faculty member to oversee growth of the School’s $38.5 million research portfolio.

Toxic metal found naturally is associated with variety of diseases.

Ester Villalonga Olives, PhD, MsC, is in the first cohort of a new program for junior faculty of diverse backgrounds.

Multi-Disciplinary Team of Researchers – Including UMSOP’s Mass Spectrometry Experts – Identify Mechanism of Protection Conferred by Probiotic Supplement

Information about the molecular shape of the viruses that cause COVID-19, SARS, and MERS reveals structural similarities that suggest possible drug treatments.